Mycophyto
$2.1M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Mycophyto is currently valued at N/A as of December 12, 2024. The company has raised a total of $6.8M in funding.
Investment Perspective
Mycophyto's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Mycophyto Worth in 2025?
As of 2025, Mycophyto is valued at N/A, based on the company's Grant funding round in December 12, 2024. This valuation positions Mycophyto as one of the leading private companies in the sector.
Mycophyto Valuation History
Mycophyto's funding history demonstrates steady growth and investor confidence.
How Mycophyto Valuation is Determined
Private company valuations like Mycophyto's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Mycophyto Valuation FAQs
Is Mycophyto profitable?
Mycophyto has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Mycophyto's valuation compare to competitors?
Mycophyto is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Mycophyto IPO?
Mycophyto has not announced plans for an initial public offering. Until an IPO, investors can access Mycophyto shares through secondary market platforms.